Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Asset Writedowns and Impairment (2021)

Historic Asset Writedowns and Impairment for Conmed (CNMD) over the last 1 years, with Q3 2021 value amounting to $899000.0.

  • Conmed's Asset Writedowns and Impairment changed N/A to $899000.0 in Q3 2021 from the same period last year, while for Dec 2022 it was $899000.0, marking a year-over-year change of. This contributed to the annual value of $363000.0 for FY2025, which is N/A changed from last year.
  • Per Conmed's latest filing, its Asset Writedowns and Impairment stood at $899000.0 for Q3 2021.
  • In the past 5 years, Conmed's Asset Writedowns and Impairment registered a high of $899000.0 during Q3 2021, and its lowest value of $899000.0 during Q3 2021.